Vitaly Margulis

Memorial Sloan Kettering Cancer Center — United States

Medicine · Health Sciences

71h-index19.4kcitations808works2.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Bladder and Urothelial Cancer Treatments(417), Renal cell carcinoma treatment(333), Urinary and Genital Oncology Studies(250), Renal and related cancers(151), Cancer Genomics and Diagnostics(83)

Publications805 total

Neoadjuvant versus adjuvant chemotherapy for upper tract urothelial carcinoma in the setting of clinical node positive disease: analysis of the ROBUUST registry
World Journal of Urology·2025
Neoadjuvant pembrolizumab and tyrosine kinase inhibitor to facilitate imperative partial nephrectomy for renal cell carcinoma
Urologic Oncology Seminars and Original Investigations·2025
Radiologic, Pathologic, and Deep Learning Predictors of Response to Immune Checkpoint Blockade in Renal Cell Carcinoma Patients Undergoing Post-Treatment Nephrectomy
2025Open Access
A structured training curriculum for robot‐assisted radical nephroureterectomy: a Delphi consensus study
British Journal of Urology·2025
Molecular Features and Actionable Gene Targets of Testicular Germ Cell Tumors in a Real-World Setting
International Journal of Molecular Sciences·2025· 1 citedOpen Access
Smoking is Associated With Poorer Survival Outcomes Following Nephroureterectomy for Upper Tract Urothelial Cancer
Urology·2025
Oncologic and survival outcomes in patients undergoing radical nephroureterectomy with preoperative or iatrogenic dialysis dependence
Urologic Oncology Seminars and Original Investigations·2025
Radiomic Profiling of Tumor Thrombus for Predicting Recurrence in Renal Cell Carcinoma
European Urology Open Science·2025Open Access
Predictors and Patterns of Nonurothelial Recurrence After Nephroureterectomy for Upper Tract Urothelial Carcinoma (UCAN Collaboration)
The Journal of Urology·2025· 1 citedOpen Access
Glycosaminoglycan-driven lipoprotein uptake protects tumours from ferroptosis
Nature·2025· 27 citedOpen Access
ENLIGHTED phase 3 study: Interim results of efficacy and safety of padeliporfin vascular targeted photodynamic therapy (VTP) in the treatment of low-grade upper tract urothelial cancer (LG UTUC).
Journal of Clinical Oncology·2025· 1 cited
Neoadjuvant stereotactic radiotherapy and enfortumab vedotin: A phase I/II study for localized, cisplatin ineligible, muscle invasive bladder cancer (STAR-EV).
Journal of Clinical Oncology·2025
New Insights into Upper Tract Urothelial Carcinoma: Lessons Learned from the ROBUUST Collaborative Study
Cancers·2025· 2 citedOpen Access
Editorial Comment: Economic Impact Model of Incorporating Cxbladder Monitor in the Surveillance of Nonmuscle Invasive Bladder Cancer
JU Open Plus·2025Open Access
Predicting Recurrence After Surgical Resection for High-Risk Localized Renal Cell Carcinoma: A Radiomics Clinical Integration Approach
The Journal of Urology·2025· 3 cited
Abstract 4704: Development of a novel zebrafish patient-derived xenograft (zPDX) platform for functional precision cancer medicine for immune checkpoint (ICIs) and tyrosine kinase inhibitors (TKIs) of renal cell carcinoma (RCC)
Cancer Research·2025
Combined neoadjuvant and adjuvant therapy versus adjuvant therapy in high-risk upper tract urothelial carcinoma: a propensity matched multicenter analysis (ROBUUST 2.0 International Collaborative Group)
World Journal of Urology·2025
IP12-14 EFFICACY AND SAFETY OF PADELIPORFIN VASCULAR TARGETED PHOTODYNAMIC THERAPY (VTP) FOR TREATMENT OF LOW-GRADE UPPER TRACT UROTHELIAL CANCER (LGUTUC): ENLIGHTED PHASE 3 STUDY
The Journal of Urology·2025
IP12-20 VALIDATION OF THE AUA CLINICAL RISK CATEGORIES FOR NON-METASTATIC UPPER TRACT UROTHELIAL CARCINOMA: ANALYSIS OF THE ROBUUST 3.0 REGISTRY
The Journal of Urology·2025
IP25-28 SOCIODEMOGRAPHIC FACTORS AS A PREDICTIVE FACTOR OF OUTCOME AMONG TESTICULAR CANCER PATIENTS
The Journal of Urology·2025
page 1 of 41Next →

Frequent Co-authors

Shahrokh F. Shariat(30), Yair Lotan(28), Christopher G. Wood(26), Jay D. Raman(22), Pierre I. Karakiewicz(21), Richard Zigeuner(18), Alon Z. Weizer(18), Francesco Montorsi(18), Mesut Remzi(17), Eiji Kikuchi(16), Marco Roscigno(15), Karim Bensalah(15), Christian Bolenz(14), Theresa M. Koppie(12), Wassim Kassouf(12), Cord Langner(11), Surena F. Matin(10), Arthur I. Sagalowsky(10), Giacomo Novara(10), Mario I. Fernández(10)